Incubate Coalition

WASHINGTON ( December 2 ) -- Yesterday, the United States and the United Kingdom announced  a new agreement on pharmaceutical pricing as part of the Economic Prosperity Deal (EPD). The agreement is expected to increase the U.K.'s valuation of new medicines and expand its long-term investment in innovative therapies. The United States, in turn, committed to exempt U.K.-origin pharmaceuticals from any future Section 232 tariffs and to refrain from targeting U.K. pricing policies in potential...

WASHINGTON ( Sep 30 ) -- Today, the Trump administration announced its first agreement with a manufacturer to bring most-favored-nation...

September 13th -- or 9/13 Day -- is a reminder of the harmful provision in the Inflation Reduction Act commonly known as the pill...